Investment Strategy

Starlink Capital is striving to build strong business partnerships. We are actively looking to expand our product market through the in-licensing and acquisition products (both in-market or in late-stage development)

 

  • Invest in the development of novel pharmaceutical products – pre-clinical or clinical stages.

 

 

  • Strategic investment to obtain licensing rights in China or Greater Asia.